Bio-Tech Pharmacal is a leading player in the manufacturing industry, with a primary focus on the production of all-natural vitamins and supplements. Established in 1984, the company prides itself on the core values of purity, potency, and quality, which have been the driving force behind its operations for the past 35 years. Bio-Tech Pharmacal is headquartered in the United States and holds a significant global presence, aiming to support health worldwide by adhering to strict cGMP guidelines in the creation of pure and high-quality nutraceuticals. Notably, over 100 research institutions rely on Bio-Tech's products for medical research and studies, emphasizing the company's reputation for pharmaceutical-grade nutraceuticals. Furthermore, their products are highly bioavailable and free from artificial additives such as dyes, talc, binders, artificial colors, and synthetic flavors. With a commitment to excellence and a strong foothold in the industry, Bio-Tech Pharmacal represents an intriguing prospect for potential venture capital investors seeking opportunities in the manufacturing and health sectors.
There is no investment information
No recent news or press coverage available for Bio-Tech Pharmacal.